1. The Phenolic compound Kaempferol overcomes 5-fluorouracil resistance in human resistant LS174 colon cancer cells
   Ichrak Riahi-Chebbi et al, 2019, Scientific Reports CrossRef
2. Can Prohibitin 1 be a Safeguard against liver disease?
   Lei Xia et al, 2019, Annals of Hepatology CrossRef
3. The Interplay Between the MYC Oncogene and Ribosomal Proteins in Osteosarcoma Onset and Progression: Potential Mechanisms and Indication of Candidate Therapeutic Targets
   Ania Naila Guerrieri et al, 2024, International Journal of Molecular Sciences CrossRef
4. Significance of prohibitin domain family in tumorigenesis and its implication in cancer diagnosis and treatment
   Jie Yang et al, 2018, Cell Death & Disease CrossRef
5. Targeted sequencing reveals genetic variants associated with sensitivity of 79 human cancer xenografts to anticancer drugs
   Chihiro Udagawa et al, 2017, Experimental and Therapeutic Medicine CrossRef
6. Expression of Livin and PlGF in human osteosarcoma is associated with tumor progression and clinical outcome
   Kuo Sun et al, 2018, Oncology Letters CrossRef
7. Retracted: miR-155 Affects Osteosarcoma MG-63 Cell Autophagy Induced by Adriamycin Through Regulating PTEN-PI3K/AKT/mTOR Signaling Pathway
   Lin Wang et al, 2018, Cancer Biotherapy and Radiopharmaceuticals CrossRef
8. Pseudogene PHBP1 promotes esophageal squamous cell carcinoma proliferation by increasing its cognate gene PHB expression
   Feiyue Feng et al, 2017, Oncotarget CrossRef
9. MiR-200-3p inhibits tumor cell proliferation and induces apoptosis by upregulation of FOXO1 in osteosarcoma cells
   Yuchun Li et al, 2018, Molecular & Cellular Toxicology CrossRef
10. Prohibitin regulates mTOR pathway via interaction with FKBP8
    Jiahui Zhang et al, 2021, Frontiers of Medicine CrossRef
11. Lamprey prohibitin 2 inhibits non-small cell lung carcinoma cell proliferation by down-regulating the expression and phosphorylation levels of cell cycle-associated proteins
    Xue Zhang et al, 2023, Fish & Shellfish Immunology CrossRef